ICD10 code of Mantle Cell Lymphoma and ICD9 code

The primary ICD-10-CM code for Mantle Cell Lymphoma is C83.1, specifically C83.10 for unspecified sites, while the corresponding ICD-9-CM code is 202.88. These diagnostic codes are essential for medical billing, insurance authorization, and tracking the clinical progression of Mantle Cell Lymphoma within healthcare systems.

What is the clinical classification of Mantle Cell Lymphoma?

Mantle Cell Lymphoma is a rare, aggressive B-cell non-Hodgkin lymphoma. Because it involves the overproduction of abnormal cells, accurate coding is vital for accessing specialized therapies. While ICD-10 and ICD-9 codes provide a foundation for administrative records, clinicians often supplement these with the World Health Organization (WHO) classification to better define the biological subtype of the Mantle Cell Lymphoma.

How are diagnostic codes used for Mantle Cell Lymphoma?

Coding for Mantle Cell Lymphoma ensures that patients receive appropriate coverage for complex treatments, such as Bruton tyrosine kinase (BTK) inhibitors or CAR T-cell therapy. Accurate documentation helps oncologists track the stage and site of the disease, which is critical given that Mantle Cell Lymphoma often presents with extranodal involvement, such as in the gastrointestinal tract or bone marrow.

Key considerations for Mantle Cell Lymphoma diagnosis

Beyond the ICD-10 code C83.1, medical professionals utilize several diagnostic benchmarks to confirm the presence and status of the disease:

• Cyclin D1 overexpression: Over 95% of Mantle Cell Lymphoma cases exhibit this marker.


• SOX11 expression: A key nuclear marker used to differentiate subtypes.


• t(11;14) translocation: The hallmark genetic alteration involving the IGH and CCND1 genes.


• Ki-67 proliferation index: A measure used to determine how rapidly the lymphoma cells are dividing.

Next steps

• Consult with a hematologist-oncologist specializing in lymphoid malignancies to review your specific diagnostic pathology report.


• Verify that your medical records correctly reflect your diagnosis to ensure seamless access to insurance-covered clinical trials.


• Connect with the DiseaseMaps.org community to share experiences and find support from others navigating a Mantle Cell Lymphoma diagnosis.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• National Cancer Institute (NCI) - Mantle Cell Lymphoma Treatment PDQ.


• Orphanet (ORPHA: 545) - Mantle Cell Lymphoma.


• NIH Genetic and Rare Diseases Information Center (GARD).


• The Lymphoma Research Foundation - Understanding Mantle Cell Lymphoma.